.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Baxter
Novartis
Citi
QuintilesIMS
Express Scripts
US Department of Justice
Boehringer Ingelheim
US Army
McKinsey

Generated: June 29, 2017

DrugPatentWatch Database Preview

LERITINE Drug Profile

« Back to Dashboard

What is the patent landscape for Leritine, and when can generic versions of Leritine launch?

Leritine is a drug marketed by Merck and is included in two NDAs.

The generic ingredient in LERITINE is anileridine hydrochloride. Additional details are available on the anileridine hydrochloride profile page.

Summary for Tradename: LERITINE

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list11
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LERITINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
LERITINE
anileridine phosphate
INJECTABLE;INJECTION010520-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Merck
LERITINE
anileridine hydrochloride
TABLET;ORAL010585-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
US Army
AstraZeneca
Fish and Richardson
UBS
Teva
Queensland Health
US Department of Justice
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot